•  
  •  
 

Editorial Policies

Contents

Philosophy of Pharmaceutical Sciences and Research

For more information, please see the Pharmaceutical Sciences and Research Aims and Scope page.

Who Can Submit?

Anyone may submit an original article to be considered for publication in Pharmaceutical Sciences and Research provided he or she owns the copyright to the work being submitted or is authorized by the copyright owner or owners to submit the article. Authors are the initial owners of the copyright to their works (an exception to this might exist in the non-academic world if the authors have, as a condition of employment, agreed to transfer the copyright to their employer).

{ top }

General Submission Rules

Submitted articles must not have been published previously, nor be forthcoming in an archival journal or book (print or electronic). Please note: "publication" in a working-paper series does not constitute prior publication. In addition, by submitting material to Pharmaceutical Sciences and Research, the author declares that the material is not currently under review at another journal (electronic or print) and that he or she will not submit the material to another journal (electronic or print) before completion of the editorial decision process at Pharmaceutical Sciences and Research. If you have concerns about the submission terms for Pharmaceutical Sciences and Research, please contact the editors.

{ top }

Formatting Requirements

Pharmaceutical Sciences and Research has no general rules about the formatting of articles upon initial submission. There are, however, rules governing the formatting of the final submission. See the Final Manuscript Preparation Guidelines for details. Although bepress can provide limited technical support, it is ultimately the author's responsibility to produce an electronic version of the article as a high-quality PDF (Adobe's Portable Document Format) file, or a Microsoft Word, WordPerfect or RTF file that can be converted to a PDF file.

It is understood that the current state of technology of Adobe's Portable Document Format (PDF) is such that there are no, and can be no, guarantees that PDF documents will work seamlessly with all possible hardware and software configurations that readers may have.

{ top }

Copyright Notice

The copyrights of all materials published in Pharmaceutical Sciences and Research (PSR) will be held by the respective authors. Authors retain copyrights and grant Pharmaceutical Sciences and Research (PSR) the rights to publish the work licensed under a Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) that allows others to remix, adapt, and build upon the work non-commercially with an acknowledgement of the work’s authorship and initial publication in Pharmaceutical Sciences and Research (PSR).

{ top }

Open Access Policy

Pharmaceutical Sciences and Research (PSR) is an open-access journal which provides immediate, worldwide, barrier-free access to the full text of all published articles with no access charge for readers or their institutions, on the principle that making research freely available to the public supports a greater global exchange of knowledge. Readers are entitled to read, download, copy, distribute, print, search, or link to the full texts of all articles in Pharmaceutical Sciences and Research (PSR) under a Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).

{ top }

Generative AI Policies

1. Scope and Purpose

This policy regulates the use of generative artificial intelligence (GenAI) tools, including large language models, AI-based translation systems, generative image tools, code-writing assistants, and predictive AI models—by authos, editors, and peer reviewers involved in the preparation, submission, review, and publication of manuscripts in Pharmaceutical Sciences and Research (PSR).

PSR adopts the core principles articulated by Committee on Publication Ethics (COPE) and the guidelines of major academic publishers. GenAI may support, but must not replace human intellectual contribution, judgment, or accountability. Transparency, research integrity, confidentiality, and responsible use are essential at all stages.

2. Foundational Principles

a. Human responsibility is non-delegable

GenAI tools cannot be listed as authors. All named authors must be human and remain fully accountable for the integrity, originality, accuracy, and ethical compliance of their manuscripts.

b. GenAI may assist, but must not lead or replace scientific reasoning

AI-generated text, analyses, or images must not be accepted without critical human review, verification, and where needed, independent validation.

c. Confidentiality and intellectual property rights must be protected

Manuscript content, proprietary data, patient information, or unpublished materials must not be uploaded to public AI platforms.

d. Transparency is mandatory

Any use of GenAI must be disclosed clearly and accurately.

3. Use of GenAI by authors

3.1 Permitted Uses (with conditions)

● Authors may use GenAI tools for language editing, improving clarity and readability, checking grammar, or assisting with formatting, provided that such use does not change the scientific meaning, generate new claims, or introduce unverified content.

● GenAI may be used for non-decisive support such as drafting outlines, suggesting structure, or rephrasing non-sensitive text, as long as authors critically review, substantively revise, and take full responsibility dor the final text.

3.2 Prohibited uses

● GenAI must not be used to fabricate, manipulate, or alter data, results, images, or statistical analyses that are then presented as original research findings.

● Authors must not upload confidential, proprietary, or identifiable research data (e.g., patient information, clinical trial data, unpublished manuscripts) to public GenAI platforms that retain or use data for model training.

3.3 Use of GenAI in Scientific Research

If GenAI models are used as part of the research workflow—e.g., for predictive modeling, molecular generation, docking simulations, QSAR analysis, image synthesis, or data augmentation—authors must:

● Describe the tool, version, model type, and parameters used.

● Provide a transparent account of training data (if known), datasets, and algorithms.

● Independently validate all AI-generated predictions with established scientific methods.

● Explicitly distinguish between empirical and AI-derived results.

● Provide reproducibility details sufficient for peer evaluation AI-generated scientific outputs must not be presented without verification.

3.4 Disclosure Requirements

When GenAI tools are used in manuscript drafting or editing, authors must clearly disclose this in the manuscript (e.g. in the Methods or Acknowledgements section), specifying the the tool name, provider, version (if available), and the scope of use, in line with APA’s guidance.

4. Use of GenAI by Editors and Peer Reviewers

● Editors and peer reviewers must not upload manuscript (in whole or in substantial part) to public GenAI services for the purpose of peer review or editorial decision-making, in order to preserve confidentiality and protect authors’ intellectual property.

● Editors and reviewers may use institutional or controlled tools for screening and quality checks, provided confidentiality is maintained and all judgments remain under human oversight.

● As part of its quality control and ethical screening workflow, PSR routinely uses Trinka AI to assist in detecting potential AI-generated content, assessing language quality, and identifying possible integrity issues in submitted manuscripts at the Initial Screening stage and, if needed during revision evaluation.

● Trinka AI’s outputs serve only as decision-support signals; final judgments about GenAI misuse, scientific validity, and ethical compliance are always made by human editors and peer reviewers, in line with COPE’s emphasis on human responsibility.

5. Monitoring, Investigation, and Sanctions

● PSR resevers the right to use AI-detection and text-analytics tools, including Trinka AI, alongside manual assessment to investigate potential misuse of GenAI in submitted manuscripts.

● Suspected violations of this policy—such as undisclosed substantial AI-generated content, fabricated data, or breaches of confidentiality—will be handled according to the journal’s publication ethics procedures, which may include manuscript rejection, publication of corrections or retractions, and notification of authors’ institutions.

6. Policy Review and Updates

This policy will be reviewed regularly and updated to reflect advances in GenAI technologies, evolving ethical guidance, and ongoing recommendations from COPE and major academic publishers.

{ top }

General Terms and Conditions of Use

Users of the UI Scholars Hub website and/or software agree not to misuse the UI Scholars Hub service or software in any way.

The failure of UI Scholars Hub to exercise or enforce any right or provision in the policies or the Submission Agreement does not constitute a waiver of such right or provision. If any term of the Submission Agreement or these policies is found to be invalid, the parties nevertheless agree that the court should endeavour to give effect to the parties' intentions as reflected in the provision, and the other provisions of the Submission Agreement, and these policies remain in full force and effect. These policies and the Submission Agreement constitute the entire agreement between UI Scholars Hub and the Author(s) regarding submission of the Article.

{ top }